Type your tag names separated by a space and hit enter

    Telavancin

    Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D. BCPS
    Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
    Telavancin is a topic covered in the Johns Hopkins ABX Guide.

    To view the entire topic, please or purchase a subscription.

    Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

    Pediatrics Central

    -- The first section of this topic is shown below --

    INDICATIONS

    FDA

    • Complicated skin and skin structure infections caused by susceptible Gram-positive bacteria (S. aureus including MRSA, S. pyogenes, other Strep species [S. agalactiae, S. anginosusgroup], or vancomycin sensitive E. faecalis).
    • HAP and VAP caused by susceptible isolates of S. aureus.
      • It should be reserved for use when alternative agents are not suitable.

    NON-FDA APPROVED USES

    • S. aureus bacteremia and right-sided endocarditis randomized trial comparing telavancin with standard therapy is under way (NCT02208063)

    -- To view the remaining sections of this topic, please or purchase a subscription --

    Last updated: October 2, 2018

    Citation

    Avdic, Edina, and Paul A Pham. "Telavancin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540538/all/Telavancin.
    Avdic E, Pham PA. Telavancin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540538/all/Telavancin. Accessed March 19, 2019.
    Avdic, E., & Pham, P. A. (2018). Telavancin. In Johns Hopkins ABX Guide. Available from https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540538/all/Telavancin
    Avdic E, Pham PA. Telavancin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2019 March 19]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540538/all/Telavancin.
    * Article titles in AMA citation format should be in sentence-case
    TY - ELEC T1 - Telavancin ID - 540538 A1 - Avdic,Edina,Pharm.D. AU - Pham,Paul,Pharm.D. BCPS Y1 - 2018/10/02/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540538/all/Telavancin PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -